IRIS

Bosentan effects in inoperable forms of chronic thromboembolic pulmonary hypertension Study Group. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial

D'ARMINI, ANDREA MARIA;
2008-01-01
2008
The Cardiovascular & Respiratory Systems category covers resources concerned with all aspects of cardiovascular and thoracic surgery and respiratory diseases. Topics include circulation, cardiovascular technology and measurement, cardiovascular pharmacology and therapy, hypertension, heart and lung transplantation, arteries, arteriosclerosis, thrombosis, angiology, perfusion, stroke, as well as all types of respiratory and lung diseases.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
sì
WOS:000261757200002
2-s2.0-57449103127
Sì, ma tipo non specificato
Inglese
Internazionale
ELETTRONICO
52
25
2127
2134
19095129
Ipertensione polmonare cronica tromboembolica; pazienti inoperabili; terapia medica
14
info:eu-repo/semantics/article
262
X., Jais; D'Armini, ANDREA MARIA; P., Jansa; A., Torbicki; M., Delcroix; H. A., Ghofrani; M. M., Hoeper; I. M., Lang; E., Mayer; J., Pepke Zaba; L., P...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/139635
Citazioni
  • ???jsp.display-item.citation.pmc??? 134
  • Scopus 513
  • ???jsp.display-item.citation.isi??? 443
social impact